Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sedvall

Showing results (131-140 of 231) with videos related to

Pageof 24
Sort By:
Neuroradiology|January 1, 1986
Radionuclide cisternography and computed tomography in 30 healthy volunteersG Bergstrand, G Oxenstierna, L Flyckt, et al.
Psychopharmacology|January 1, 1992
[11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomographyC Halldin, L Farde, J E Litton, et al.
Biological Psychology|May 1, 1984
Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituationA Bartfai, G Edman, S E Levander, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.
Acta Psychiatrica Scandinavica|August 1, 1986
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatmentG Wik, F A Wiesel, P Eneroth, et al.
Psychopharmacology|October 1, 1995
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in manP Karlsson, G Sedvall, C Halldin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1973
The use of stable oxygen isotopes for labeling of homovanillic acid in rat brain in vivoG Sedvall, A Mayevsky, C G Fri, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies of dopamine receptors in relation to antipsychotic drug treatmentL Farde, A L Nordström, C Halldin, et al.
Journal of Neurochemistry|July 1, 1984
5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factorsO Beck, S Borg, G Edman, et al.
Psychiatry Research|August 1, 1983
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteersH Nybäck, B M Berggren, T Hindmarsh, et al.
Pageof 24

Showing results (131-140 of 231) with videos related to

Sort By:
Pageof 24
Neuroradiology|January 1, 1986
Radionuclide cisternography and computed tomography in 30 healthy volunteersG Bergstrand, G Oxenstierna, L Flyckt, et al.
Psychopharmacology|January 1, 1992
[11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomographyC Halldin, L Farde, J E Litton, et al.
Biological Psychology|May 1, 1984
Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituationA Bartfai, G Edman, S E Levander, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.
Acta Psychiatrica Scandinavica|August 1, 1986
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatmentG Wik, F A Wiesel, P Eneroth, et al.
Psychopharmacology|October 1, 1995
Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in manP Karlsson, G Sedvall, C Halldin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1973
The use of stable oxygen isotopes for labeling of homovanillic acid in rat brain in vivoG Sedvall, A Mayevsky, C G Fri, et al.
Clinical Neuropharmacology|January 1, 1992
PET studies of dopamine receptors in relation to antipsychotic drug treatmentL Farde, A L Nordström, C Halldin, et al.
Journal of Neurochemistry|July 1, 1984
5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factorsO Beck, S Borg, G Edman, et al.
Psychiatry Research|August 1, 1983
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteersH Nybäck, B M Berggren, T Hindmarsh, et al.
Pageof 24